Adjuvant chemotherapy in young women with breast cancer.
Rodríguez-Lescure
Alvaro
A
Department of Medical Oncology, Hospital General Universitario de Elche, Calle Cami Almassera 11, 03203 Elche, Spain. alescure@terra.es
D000328:Adult; D000367:Age Factors; D000568:Amenorrhea / Q000150:complications; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000601:surgery; D017024:Chemotherapy, Adjuvant; D003520:Cyclophosphamide / Q000627:therapeutic use; D005260:Female; D005472:Fluorouracil / Q000627:therapeutic use; D018734:Genes, erbB-2; D006801:Humans; D008727:Methotrexate / Q000627:therapeutic use; D016649:Primary Ovarian Insufficiency / Q000150:complications; D012307:Risk Factors; D018426:SEER Program / Q000706:statistics & numerical data; D043823:Taxoids / Q000627:therapeutic use
D000970:Antineoplastic Agents; D043823:Taxoids; D003520:Cyclophosphamide; D005472:Fluorouracil; D008727:Methotrexate